The Discovery of SIV and Development of Monkey Models for the Study of HIV/AIDS. Ronald C Desrosiers University of Miami Miller School of Medicine

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "The Discovery of SIV and Development of Monkey Models for the Study of HIV/AIDS. Ronald C Desrosiers University of Miami Miller School of Medicine"

Transcription

1 The Discovery of SIV and Development of Monkey Models for the Study of HIV/AIDS Ronald C Desrosiers University of Miami Miller School of Medicine

2

3

4 10 FEBRUARY 1984 Infectious Diseases Branch, National Institute for Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20205, USA Feb. 10, 1984 Feb. 11, 1984 MANETH GRAVELL WILLIAM T. LONDON REBECCA S. HAMILTON JOHN L. SEVER THE LANCET, February 11, 1984 TRANSMISSION OF SIMIAN AIDS WITH TYPE D RETROVIRUS ISOLATE SIR,-Monkeys of the genus Macaca housed at two regional primate centres in the USA have acquired by natural means a highly fatal immunosuppressive disease which resembles human acquired immunodeficiency syndrome (AIDS).3,4 Like human AIDS, the simian disease (SAIDS) is characterised by profound immunosuppression, multiple opportunistic infections, chronic wasting, malignancy in some instances, and a high death rate.3-7 Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland Department of Virology, St Jude Children s Research Hospital, Memphis, Tennessee Frederick Cancer Research Facility, Frederick, Maryland California Primate Research Center; and Department of Medical Pathology University of California at Davis ALBERT Z. KAPIKIAN GOPAL MURTI LARRY O. ARTHUR RAYMOND V. GILDEN KENT G. OSBORN PRESTON A. MARX ROY V. HENRICKSON MURRAY B. GARDNER 2. Vetter H, Fischer M, Muller-Rensing R, Vetter W, Winterberg B. [131I]-metaiodobenzylguanidine in treatment of malignant phaeochromocytomas Lancet 1983; ii: Henrickson RV, Osborn KG, Madden DL, et al. Epidemic of acquired immunodeficiency in rhesus monkeys. Lancet 1983; i: Hunt RD, Blake BJ, Chalifoux LV, et al. Transmission of naturally occurring lymphoma in macaque monkeys. Proc Natl Acad Sci USA 1983; 80: London WT, Madden DL, Gravell M, et al. Experimental transmission of simian acquired immunodeficiency syndrome (SAIDS) and Kaposi-like skin lesions. Lancet 1983, ii Gravell M, London WT, Houff SA, et al. Transmission of simian acquired immunodeficiency syndrome (SAIDS) with blood or filtered plasma. Science 1984; 223: Litvin NL, King NW, Daniel MD, et al. Experimental transmission of macaque AIDS by means of inoculation of macaque lymphoma tissue. Lancet 1983; ii:

5

6

7 Science June 7, 1985

8

9 Mm Mm SIVmac251 Lymphoma and M. avium in rhesus macaques at NEPRC Mm Mm Mm Mm Mm ?? Mm SIVmac239 Natural SIVmac identified at NEPRC in 1987 serological survey Origins of SIV at NEPRC Keith Mansfield et al Epidemic of lymphoma and M. avium in rhesus macaques at CNPRC Cercocebus torquatus atys asymptomatically infected with SIVsm at CNPRC AIDS in M. arctoides at CNPRC Derivation and suspected origin of SIVmac at NEPRC

10 Induction of AIDS in Rhesus Monkeys by Molecularly Cloned Simian Immunodeficiency Virus HARRY KESTLER, TOSHIAKI KODAMA, DOUGLAS RINGLER, MARTA MARTHAS, NIELS PEDERSEN, ANDREW LACKNER, DEAN REGIER, PRABHAT SEHGAL, MUTHIAH DANIEL, NORVAL KING, RONALD DESROSIERS* Better understanding of the pathogenesis of acquired immunodeficiency syndrome (AIDS) would be greatly facilitated by a relevant animal model that uses molecularly cloned virus of defined sequence to induce the disease. Such a system would also be of great value for AIDS vaccine research. An infectious molecular clone of simian immunodeficiency virus (SIV) was identified that induces AIDS in common rhesus monkeys in a time frame suitable for laboratory investigation. These results provide another strong link in the chain of evidence for the viral etiology of AIDS. More importantly, they define a system for molecular dissection of the determinants of AIDS pathogenesis. Science June 1, 1990

11 The infectious, pathogenic SIVmac239 clone The first pathogenic clone to be defined for any lentivirus At the time, the viral etiology of AIDS in humans was being questioned (Duesberg). Induction of AIDS in monkeys by 10,279 base pairs of cloned DNA provided unambiguous evidence even for the skeptics SIVmac239, derivatives of it, and other such clones have proven enormously useful Homogeneous virus of defined sequence for a better controlled laboratory setting Any gene, any nucleotide, any amino acid can be changed and the effects on pathogenic potential, tropism, neut sensitivity, etc can be determined

12 One Application Relative Importance and Functional Role of the so-called Auxiliary Genes

13 Δvpr > Δvpx > ΔvprΔvpx Δnef > Δ3 > Δ3x > Δ4 >> Δvif > Δ5.

14

15

16 A long, long time ago, in a pub not so far away Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. NEJM 332:228 Sully Uncle Ron

17

18

19

20

21

22

23

24

25 1994 Idea squashed

26 Two important points regarding the concept of live attenuated vaccines for HIV 1. While SIVΔnef and SIVΔ3 provide strong protection against challenge by SIV strains identical or closely matched in sequence, these live attenuated vaccines do NOT provide very good protection against heterologous SIV strains. 2. This situation is probably analogous to the inability of infection by one HIV strain to routinely protect against superinfection by a different HIV strain

27 Estimated time of infection for the 10 cases of superinfection observed among 56 women in the Mombasa cohort Years PI Intersubtype Intrasubtype The intervals are variable due to differences in availability of samples for testing.

28 Current uses of SIV and SHIV models Better understanding of pathogenesis Inform and guide development of vaccine concepts for use in humans Investigation of novel therapy strategies, including cure strategies

29 Current Emphases in my Lab Pathogenesis Replication-competent recombinant herpesvirus as a preventive vaccine AAV vector for long-term delivery of monoclonal antibodies for prevention and therapy

30 Partial List of Trainees Past Jae Jung Frank Kirchoff Blossom Damania Welkin Johnson David Evans Michaela Gack Alexander Hahn Present Young Shin Sebastian Fuchs Jose Martinez-Navio Georg Bischof James Termini Shara Pantry Zach Silver

31 Critical Colleagues over the Years Bernhard Fleckenstein Larry Arthur Jeff Lifson John Sullivan David Watkins and Mario Stevenson

32 AAV Delivery of Monoclonal Antibodies for the Prevention and Treatment of HIV Infection

33 Need for alternate strategies Long-term delivery of mabs is one such alternate strategy Such antibody-based strategies are made possible by an incredible array of mabs with potent, broadly-neutralizing activity against HIV that have been isolated and characterized over the last several years

34 AAV as a long-term delivery vehicle - ideal in many respects The only protein expressed from AAV vector comes from the transgene put into it Proven ability to achieve long-term expression of the transgene product Outstanding safety record in human gene therapy trials Little or no integration of AAV vector DNA into host genome sequences

35 400 Week 187 (> 3.5 years) Concentration of 5L7 IgG1 in serum (µg/ml) Time (weeks) after AAV administration

36 Viral Loads by Jeff Lifson

37 Antibody µg/ml Monkey rh C9-LS 3BNC117-LS 10E8-LS SHIV-AD8 VL SHIV-AD8 Log10 copies/ml Weeks post-aav inoculation

38 Molecular Therapy Received 14 August 2015; accepted 1 October 2015; advance online publication 3 November doi: /mt

39

40 SERIAL PASSAGE OF SIV sm : ACQUISITION / SELECTION OF A PATHOGENIC PHENOTYPE Adapted from K Mansfield, R Desrosiers and M Martin

41

42 Fields Virology

43

44

45

46 Keith Mansfield

Should There be Further Efficacy Testing of T-T cell Based Vaccines that do not Induce Broadly Neutralizing Antibodies?

Should There be Further Efficacy Testing of T-T cell Based Vaccines that do not Induce Broadly Neutralizing Antibodies? Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services Should There be Further Efficacy

More information

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART BIOE 301 LECTURE 10 MITALI BANERJEE A VACCINE FOR HIV HIV HAART Visit wikipedia.org and learn the mechanism of action of the five classes of antiretroviral drugs. (1) Reverse transcriptase inhibitors (RTIs)

More information

ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIV(mac)251 Challenge

ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIV(mac)251 Challenge University of Massachusetts Medical School escholarship@umms Preventive and Behavioral Medicine Publications and Presentations Preventive and Behavioral Medicine 8-2012 ADCC Develops Over Time during Persistent

More information

The Effect of nef-deleted SIV Administration on Disease Progression in SIV- Infected Rhesus Macaques

The Effect of nef-deleted SIV Administration on Disease Progression in SIV- Infected Rhesus Macaques Research Article imedpub Journals http://www.imedpub.com/ Journal of HIV & Retro Virus DOI: 10.21767/2471-9676.100023 The Effect of nef-deleted SIV Administration on Disease Progression in SIV- Infected

More information

IN VIVO STUDIES ON VIRAL VIRULENCE

IN VIVO STUDIES ON VIRAL VIRULENCE IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease

More information

Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys

Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys Dan H. Barouch, M.D., Ph.D. Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Ragon Institute of MGH, MIT,

More information

Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study

Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study Note: I have added some clarifying comments to the slides -- please click on Comments under View to see them. Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a

More information

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED Viv Peut Kent Laboratory, University of Melbourne, Australia WHY ENVELOPE? Env subject to both humoral and cellular immune responses Perhaps

More information

An Evolutionary Story about HIV

An Evolutionary Story about HIV An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst

More information

X/01/$ DOI: /JVI Copyright 2001, American Society for Microbiology. All Rights Reserved.

X/01/$ DOI: /JVI Copyright 2001, American Society for Microbiology. All Rights Reserved. JOURNAL OF VIROLOGY, Apr. 2001, p. 3753 3765 Vol. 75, No. 8 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.8.3753 3765.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Route of Simian

More information

PMC ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. PLoS Pathog. 2013;9(4):e PMC

PMC ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. PLoS Pathog. 2013;9(4):e PMC Class Date Instructors Topic Papers Scott Hensley and Jianxin You Vaccine Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses. Cell. 2016 Jul 28;166(3):609 23. doi:10.1016/j.cell.2016.06.043.

More information

Massive infection and loss of memory CD4 + T cells in multiple tissues during acute SIV infection

Massive infection and loss of memory CD4 + T cells in multiple tissues during acute SIV infection Massive infection and loss of memory CD4 + T cells in multiple tissues during acute SIV infection Joseph J. Mattapallil 1, Daniel C. Douek 2, Brenna Hill 2, Yoshiaki Nishimura 3, Malcolm Martin 3 & Mario

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

Identification and Characterization of CD4 T cells actively transcribing HIV RNA in Peripheral Blood

Identification and Characterization of CD4 T cells actively transcribing HIV RNA in Peripheral Blood Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Identification and Characterization of CD4 T cells actively transcribing

More information

Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence

Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence Courtney Merriam and Shivum Desai Biology 368: Bioinformatics Loyola Marymount

More information

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP 1 Learning Objectives Recognize hazards associated with viral vectors in research and animal

More information

Table of Contents (continued)

Table of Contents (continued) Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping

More information

VIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer

VIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer VIRAL TITER COUNTS The best methods of measuring infectious lentiviral titer FLUORESCENCE CYCLES qpcr of Viral RNA SUMMARY Viral vectors are now routinely used for gene transduction in a wide variety of

More information

CELL MEDIATED IMMUNITY IN VIRUS INFECTIONS

CELL MEDIATED IMMUNITY IN VIRUS INFECTIONS 13 CELL MEDIATED IMMUNITY IN VIRUS INFECTIONS Nobel Lecture, December 8, 1996 by PETER c. DOHERTY St.Jude Children's Research Hospital, Memphis, Tennessee 38104, USA INTRODUCTION Many key concepts concerning

More information

HIV Anti-HIV Neutralizing Antibodies

HIV Anti-HIV Neutralizing Antibodies ,**/ The Japanese Society for AIDS Research The Journal of AIDS Research : HIV HIV Anti-HIV Neutralizing Antibodies * Junji SHIBATA and Shuzo MATSUSHITA * Division of Clinical Retrovirology and Infectious

More information

1. Engineering Foot-and-Mouth Disease Viruses with Improved

1. Engineering Foot-and-Mouth Disease Viruses with Improved Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Haixue Zheng, Fan Yang, Ye Jin, Jianhong Guo, Jijun He, Lvlv, Xuepeng Cai, Xiangtao Liu, Hong

More information

CROI 2016 Review: Immunology and Vaccines

CROI 2016 Review: Immunology and Vaccines Frontier AIDS Education and Training Center CROI 2016 Review: Immunology and Vaccines Meena Ramchandani MD MPH Acting Instructor, University of Washington March 2016 This presentation is intended for educational

More information

Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239

Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239 University of Massachusetts Medical School escholarship@umms Preventive and Behavioral Medicine Publications and Presentations Preventive and Behavioral Medicine 1-23-2009 Immunization with single-cycle

More information

Reviewing the Clinical Development of Zika and Chikungunya Vaccines

Reviewing the Clinical Development of Zika and Chikungunya Vaccines Reviewing the Clinical Development of Zika and Chikungunya Vaccines Stephen J. Thomas, MD Division of Infectious Diseases State University of New York Upstate Medical University October 2017 Discussion

More information

Lecture 2 Evolution in action: the HIV virus

Lecture 2 Evolution in action: the HIV virus Lecture 2 Evolution in action: the HIV virus Peter and Rosemary Grant Barry Sinervo The HIV/AIDS pandemic Life expectancy in Botswana What is HIV? What is HIV? HIV is a retrovirus (i.e., RNA-based) with

More information

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION

More information

Derivation of Neurotropic Simian Immunodeficiency Virus from

Derivation of Neurotropic Simian Immunodeficiency Virus from JOURNAL OF VIROLOGY, June 1992, p. 355-3556 22-538X/92/6355-7$2./ Copyright 1992, American Society for Microbiology Vol. 66, No. 6 Derivation of Neurotropic Simian Immunodeficiency Virus from Exclusively

More information

T cell Vaccine Strategies for HIV, the Virus. With a Thousand Faces

T cell Vaccine Strategies for HIV, the Virus. With a Thousand Faces JVI Accepts, published online ahead of print on 13 May 2009 J. Virol. doi:10.1128/jvi.00114-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

NIH Public Access Author Manuscript Nature. Author manuscript; available in PMC 2009 July 1.

NIH Public Access Author Manuscript Nature. Author manuscript; available in PMC 2009 July 1. NIH Public Access Author Manuscript Published in final edited form as: Nature. 2009 January 1; 457(7225): 87 91. doi:10.1038/nature07469. Immune Control of an SIV Challenge by a T Cell-Based Vaccine in

More information

The potential role of PD-1/PD-L1 blockade in HIV Remission and Cure Strategies

The potential role of PD-1/PD-L1 blockade in HIV Remission and Cure Strategies The potential role of PD-1/PD-L1 blockade in HIV Remission and Cure Strategies Stephen Mason Director, Discovery Virology Bristol-Myers Squibb Community Cure Workshop 2015 Sunday, Feb 22, 2015 Seattle,

More information

The use of nonhuman primates in biomedical research has led to the isolation of many

The use of nonhuman primates in biomedical research has led to the isolation of many JVI Accepts, published online ahead of print on 29 September 2010 J. Virol. doi:10.1128/jvi.01928-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Vaccination with Attenuated Simian Immunodeficiency Virus by DNA Inoculation

Vaccination with Attenuated Simian Immunodeficiency Virus by DNA Inoculation JOURNAL OF VIROLOGY, Dec. 2001, p. 11930 11934 Vol. 75, No. 23 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.23.11930 11934.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Vaccination

More information

Antibody gene transfer for HIV immunoprophylaxis

Antibody gene transfer for HIV immunoprophylaxis Antibody gene transfer for HIV immunoprophylaxis Alejandro B Balazs & Anthony P West Jr Antibody gene transfer, which involves the delivery of genes that encode potent, broadly neutralizing antibodies

More information

Diagnostic Methods of HBV and HDV infections

Diagnostic Methods of HBV and HDV infections Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection

More information

Co-evolution of host and pathogen: HIV as a model. Can Keşmir Theoretical Biology/Bioinformatics Utrecht University, NL

Co-evolution of host and pathogen: HIV as a model. Can Keşmir Theoretical Biology/Bioinformatics Utrecht University, NL Co-evolution of host and pathogen: HIV as a model Can Keşmir Theoretical Biology/Bioinformatics Utrecht University, NL c.kesmir@bio.uu.nl Outline Does HIV adapt to monomorphic human molecules? Polymorphic

More information

BBS 2711 Virology. Virus Vaccines

BBS 2711 Virology. Virus Vaccines BBS 2711 Virology Virus Vaccines Dr Paul Young, Department of Microbiology & Parasitology. p.young@mailbox.uq.edu.au Virus Vaccines First vaccine developed by Jenner in late 1700's against smallpox virus

More information

Functional Cure of SIVagm Infection in Rhesus Macaques Results in Complete Recovery of CD4 + T Cells and Is Reverted by CD8 + Cell Depletion

Functional Cure of SIVagm Infection in Rhesus Macaques Results in Complete Recovery of CD4 + T Cells and Is Reverted by CD8 + Cell Depletion Functional Cure of SIVagm Infection in Rhesus Macaques Results in Complete Recovery of CD4 + T Cells and Is Reverted by CD8 + Cell Depletion Ivona Pandrea 1,2,3, Thaidra Gaufin 4, Rajeev Gautam 4, Jan

More information

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003 Chapter 13 Viruses, Viroids, and Prions Biology 1009 Microbiology Johnson-Summer 2003 Viruses Virology-study of viruses Characteristics: acellular obligate intracellular parasites no ribosomes or means

More information

Combined IL-21 and IFNα treatment limits inflammation and delay viral rebound in ART-treated, SIV-infected macaques

Combined IL-21 and IFNα treatment limits inflammation and delay viral rebound in ART-treated, SIV-infected macaques Combined and IFNα treatment limits inflammation and delay viral rebound in ART-treated, SIV-infected macaques Mirko Paiardini Associate Professor, Emory University School of Medicine Yerkes National Primate

More information

DIAGNOSTICS ALGORITHMS IN DENGUE INFECTIONS

DIAGNOSTICS ALGORITHMS IN DENGUE INFECTIONS ECDC training Workshop on laboratory diagnosis of dengue virus infections Berlin, 23 27 January 2012 DIAGNOSTICS ALGORITHMS IN DENGUE INFECTIONS Cristina Domingo Carrasco Robert Koch Institut KINETICS

More information

The Enemy Within: Human Cytomegalovirus. Juliet V. Spencer University of San Francisco

The Enemy Within: Human Cytomegalovirus. Juliet V. Spencer University of San Francisco The Enemy Within: Human Cytomegalovirus Juliet V. Spencer University of San Francisco NCASM Spring Meeting March 8, 2014 Herpes is all around us Human Herpesviruses Clinical Presentation Herpes simplex

More information

Anti-addictive Drug Vaccine Platform

Anti-addictive Drug Vaccine Platform Anti-addictive Drug Vaccine Platform Brian J. Kelly, Ph.D. Cornell Center for Technology Enterprise and Commercialization June 21, 2012 Winning the War Strategy Use Gene Transfer Vectors to Develop Effective

More information

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza Scientometrics (2015) 105:485 495 DOI 10.1007/s11192-015-1681-8 Emerging infectious disease: trends in the literature on SARS and H7N9 influenza Deqiao Tian 1 Tao Zheng 1 Received: 19 July 2015 / Published

More information

Broadly Neutralizing Antibodies for HIV Eradication

Broadly Neutralizing Antibodies for HIV Eradication DOI 10.1007/s11904-016-0299-7 HIV PATHOGENESIS AND TREATMENT (AL LANDAY, SECTION EDITOR) Broadly Neutralizing Antibodies for HIV Eradication Kathryn E. Stephenson 1,2 & Dan H. Barouch 1,2 # The Author(s)

More information

Development of Broadly Reactive HIV-1/AIDS Virus-like Particle Vaccines. Sean Patrick McBurney. B.S. Microbiology, University of Pittsburgh, 2004

Development of Broadly Reactive HIV-1/AIDS Virus-like Particle Vaccines. Sean Patrick McBurney. B.S. Microbiology, University of Pittsburgh, 2004 Development of Broadly Reactive HIV-1/AIDS Virus-like Particle Vaccines by Sean Patrick McBurney B.S. Microbiology, University of Pittsburgh, 2004 Submitted to the Graduate Faculty of School of Medicine

More information

HIV and Challenges of Vaccine Development

HIV and Challenges of Vaccine Development Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health HIV and Challenges of Vaccine Development Richard A. Koup, MD INTEREST

More information

Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Introduction: Materials and methods:

Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Introduction: Materials and methods: Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Haixue Zheng, Fan Yang, Ye Jin, Jianhong Guo, Jijun He, Kaiqi Lian, Zixiang Zhu, Weijun Cao, Lvlv,

More information

Lynn Morris. "Plan B"- bnabs for HIV prevention

Lynn Morris. Plan B- bnabs for HIV prevention "Plan B"- bnabs for HIV prevention Lynn Morris National Institute for Communicable Diseases, a division of the National Health Laboratory Service (NHLS) of South Africa, University of the Witwatersrand,

More information

Molecular and Biological Characterization of a Neurovirulent Molecular Clone of Simian Immunodeficiency Virus

Molecular and Biological Characterization of a Neurovirulent Molecular Clone of Simian Immunodeficiency Virus JOURNAL OF VIROLOGY, Aug. 1997, p. 5790 5798 Vol. 71, No. 8 0022-538X/97/$04.00 0 Copyright 1997, American Society for Microbiology Molecular and Biological Characterization of a Neurovirulent Molecular

More information

Mother-to-Infant Transmission of Simian Immunodeficiency Virus Is Rare in Sooty Mangabeys and Is Associated with Low Viremia

Mother-to-Infant Transmission of Simian Immunodeficiency Virus Is Rare in Sooty Mangabeys and Is Associated with Low Viremia JOURNAL OF VIROLOGY, June 2011, p. 5757 5763 Vol. 85, No. 12 0022-538X/11/$12.00 doi:10.1128/jvi.02690-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Mother-to-Infant Transmission

More information

La risposta immune all infezione da virus ebola. Chiara Agrati, PhD

La risposta immune all infezione da virus ebola. Chiara Agrati, PhD La risposta immune all infezione da virus ebola Chiara Agrati, PhD Pathogenetic mechanisms This virus infection is able to: - disable the immune system, preventing an effective protective immune response

More information

HIV: A DISCOVERY OPENING THE ROAD TO NOVEL SCIENTIFIC KNOWLEDGE AND GLOBAL HEALTH IMPROVEMENT

HIV: A DISCOVERY OPENING THE ROAD TO NOVEL SCIENTIFIC KNOWLEDGE AND GLOBAL HEALTH IMPROVEMENT HIV: A DISCOVERY OPENING THE ROAD TO NOVEL SCIENTIFIC KNOWLEDGE AND GLOBAL HEALTH IMPROVEMENT Nobel Lecture, December 7, 2008 by Françoise Barré-Sinoussi Institut Pasteur, Unit of Regulation of Retroviral

More information

Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV

Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV Debra A. Wadford, University of California Davis Robert C. Kauffman, University

More information

Isolation of a Broadly Neutralizing Antibody with Low Somatic Mutation from a Chronically Infected HIV-1 Patient

Isolation of a Broadly Neutralizing Antibody with Low Somatic Mutation from a Chronically Infected HIV-1 Patient Isolation of a Broadly Neutralizing Antibody with Low Somatic Mutation from a Chronically Infected HIV-1 Patient Amanda Fabra García, Carolina Beltrán Pavez, Alberto Merino Mansilla, Cristina Xufré, Isabel

More information

Virus Panels for Assessing Vaccine-Elicited Neutralizing Antibodies

Virus Panels for Assessing Vaccine-Elicited Neutralizing Antibodies Virus Panels for Assessing Vaccine-Elicited Neutralizing Antibodies Michael Seaman, Ph.D. Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Harvard Medical School J. Virol.

More information

Depo-ProveraH Treatment Does Not Abrogate Protection from Intravenous SIV Challenge in Female Macaques Immunized with an Attenuated AIDS Virus

Depo-ProveraH Treatment Does Not Abrogate Protection from Intravenous SIV Challenge in Female Macaques Immunized with an Attenuated AIDS Virus Depo-ProveraH Treatment Does Not Abrogate Protection from Intravenous SIV Challenge in Female Macaques Immunized with an Attenuated AIDS Virus Meritxell Genescà 1,2, Michael B. McChesney 2, Christopher

More information

Challenges in Designing HIV Env Immunogens for Developing a Vaccine

Challenges in Designing HIV Env Immunogens for Developing a Vaccine b514_chapter-13.qxd 12/4/2007 3:39 PM Page 327 Chapter 13 Challenges in Designing HIV Env Immunogens for Developing a Vaccine Indresh K. Srivastava* and R. Holland Cheng Summary HIV continues to be a major

More information

Development of a NIST Standard Reference Material for Cytomegalovirus

Development of a NIST Standard Reference Material for Cytomegalovirus Development of a NIST Standard Reference Material for Cytomegalovirus Marcia Holden, Ross Haynes, Margaret Kline, John Butler (with help from David Duewer (NIST) and Steve Ellison (LGC)) Group, Biochemical

More information

Selectively Deleted In Vivo in the Absence of an Intact nef Gene

Selectively Deleted In Vivo in the Absence of an Intact nef Gene JOURNAL OF VIROLOGY, Mar. 1994, p. 2031-2037 0022-538X/94/$04.00+0 Copyright 1994, American Society for Microbiology Vol. 68, No. 3 Upstream U3 Sequences in Simian Immunodeficiency Virus Are Selectively

More information

Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D

Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D AppuzD MmcoaioLOGy, Apr. 1973, p. 539-544. Copyright i 1973 American Society for Microbiology Vol. 25, No. 4 Printed in U.SA. Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D

More information

Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B

Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B Section Director: Cliff Bellone, Ph.D. Office: Doisy Hall - R 405 Phone: 577-8449 E-Mail: bellonec@slu.edu Lecturers: James Swierkosz, Ph.D. Office: Medical School Rm. 412 Phone: 577-8430 E-Mail: swierkoszje@slu.edu

More information

Principles of Vaccination

Principles of Vaccination Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the

More information

Removal of N-Linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus gp120 Results in Redirection of B-Cell Responses to V3

Removal of N-Linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus gp120 Results in Redirection of B-Cell Responses to V3 JOURNAL OF VIROLOGY, Feb. 2004, p. 1525 1539 Vol. 78, No. 3 0022-538X/04/$08.00 0 DOI: 10.1128/JVI.78.3.1525 1539.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Removal of

More information

Chapter 14 Part One Biotechnology and Industry: Microbes at Work

Chapter 14 Part One Biotechnology and Industry: Microbes at Work Chapter 14 Part One Biotechnology and Industry: Microbes at Work Objectives: After reading Chapter 14, you should understand How biotechnology has resulted in numerous pharmaceutical products to help lessen

More information

Lentiviruses: HIV-1 Pathogenesis

Lentiviruses: HIV-1 Pathogenesis Lentiviruses: HIV-1 Pathogenesis Human Immunodeficiency Virus, HIV, computer graphic by Russell Kightley Tsafi Pe ery, Ph.D. Departments of Medicine and Biochemistry & Molecular Biology NJMS, UMDNJ. e-mail:

More information

ABSTRACT. HIV-induced immunodeficiency may be mediated by the activation of

ABSTRACT. HIV-induced immunodeficiency may be mediated by the activation of ABSTRACT MEXAS, ANGELA MARIE. CD4 + CD25 + Regulatory T Cells Are Infected and Activated Phenotypically and Functionally During Acute Infection with Feline Immunodeficiency Virus. (Under the direction

More information

Sequence Variations in Human Immunodeficiency Virus Type 1 Nef Are Associated with Different Stages of Disease

Sequence Variations in Human Immunodeficiency Virus Type 1 Nef Are Associated with Different Stages of Disease JOURNAL OF VIROLOGY, July 1999, p. 5497 5508 Vol. 73, No. 7 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Sequence Variations in Human Immunodeficiency Virus

More information

The Alphabet Soup of Viral Hepatitis Testing

The Alphabet Soup of Viral Hepatitis Testing The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,

More information

HIV INFECTION: An Overview

HIV INFECTION: An Overview HIV INFECTION: An Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ

More information

Immunodeficiency Virus Type 2 from a West African

Immunodeficiency Virus Type 2 from a West African JOURNAL OF VIROLOGY, Aug. 1991, p. 448-4485 22-58X/91/8448-6$2./ Copyright 1991, American Society for Microbiology Vol. 65, No. 8 Isolation of a Simian Immunodeficiency Virus Related to Human Immunodeficiency

More information

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV mac 239

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV mac 239 Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV mac 239 Bin Jia 1, Sharon K. Ng 1, M. Quinn DeGottardi 1, Michael Piatak Jr. 2, Eloísa Yuste

More information

Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFβ to Degrade APOBEC3 Restriction Factors

Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFβ to Degrade APOBEC3 Restriction Factors JVI Accepts, published online ahead of print on 28 December 2011 J. Virol. doi:10.1128/jvi.06950-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13

More information

Downloaded by on April 28, 2018 https://pubs.acs.org Publication Date: April 24, 1984 doi: /bk

Downloaded by on April 28, 2018 https://pubs.acs.org Publication Date: April 24, 1984 doi: /bk 1 Virus-Receptor Interactions BERNARD N. FIELDS Department of Microbiology and Molecular Genetics, Harvard Medical School, and Department of Medicine (Infectious Disease), Brigham and Women's Hospital,

More information

The humoral immune responses to IBV proteins.

The humoral immune responses to IBV proteins. The humoral immune responses to IBV proteins. E. Dan Heller and Rosa Meir The Hebrew University of Jerusalem, Israel COST FA1207 meeting WG2 + WG3, Budapest, Jan. 2015 1 IBV encodes four major structural

More information

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations. Unit 2, Lesson 2: Teacher s Edition 1 Unit 2: Lesson 2 Influenza and HIV Lesson Questions: o What steps are involved in viral infection and replication? o Why are some kinds of influenza virus more deadly

More information

Application. Animal Models in Preclinical Evaluation of sanofi pasteur Flavivirus Vaccines Dengue Tetravalent Vaccine

Application. Animal Models in Preclinical Evaluation of sanofi pasteur Flavivirus Vaccines Dengue Tetravalent Vaccine Animal Models in Preclinical Evaluation of sanofi pasteur Flavivirus Vaccines Dengue Tetravalent Vaccine Application Jean LANG M.D., Ph.D. avp R&D sanofi pasteur Dengue R&D Program Leader Fondation Merieux

More information

Immunogens and Antigen Processing: Report from a Global HIV Vaccine Enterprise Working Group

Immunogens and Antigen Processing: Report from a Global HIV Vaccine Enterprise Working Group report Immunogens and Antigen Processing: Report from a Global HIV Vaccine Enterprise Working Group John Mascola, C Richter King & Ralph Steinman on behalf of a Working Group convened by the Global HIV

More information

A global approach to HIV-1 vaccine development

A global approach to HIV-1 vaccine development A global approach to HIV-1 vaccine development The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Published Version Accessed

More information

OCCUPATIONAL HEALTH CONSIDERATIONS FOR WORK WITH VIRAL VECTORS

OCCUPATIONAL HEALTH CONSIDERATIONS FOR WORK WITH VIRAL VECTORS OCCUPATIONAL HEALTH CONSIDERATIONS FOR WORK WITH VIRAL VECTORS GARY R. FUJIMOTO, M.D. PALO ALTO MEDICAL FOUNDATION ADJUNCT ASSOCIATE CLINICAL PROFESSOR OF MEDICINE DIVISION OF INFECTIOUS DISEASES AND GEOGRAPHIC

More information

Originally published as:

Originally published as: Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681

More information

! " ## $%& &'( ) Page 1 of 7

!  ## $%& &'( ) Page 1 of 7 ! " ## $%& &'( ) *+, -+.//0 Page 1 of 7 Introduction This report reflects the discussion and conclusions of a group of experts on regulatory aspects of vaccines from national and international regulatory

More information

CDC website:

CDC website: Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of

More information

DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade

DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade CLINICAL MICROBIOLOGY REVIEWS, Apr. 2004, p. 370 389 Vol. 17, No. 2 0893-8512/04/$08.00 0 DOI: 10.1128/CMR.17.2.370 389.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. DNA

More information

A Query by HIV. I. A query by HIV. II. Recursion

A Query by HIV. I. A query by HIV. II. Recursion A Query by HIV I. A query by HIV Human immunodeficiency virus (HIV) is a kind of lentivirus (lenti- means "slow") that belongs to the Retroviridae family. HIV is known for slow disease progression. In

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH Considerations

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH Considerations INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations General Principles to Address Virus and Vector Shedding 1.0 Introduction

More information

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit

More information

Immunity and Infection. Chapter 17

Immunity and Infection. Chapter 17 Immunity and Infection Chapter 17 The Chain of Infection Transmitted through a chain of infection (six links) Pathogen: Disease causing microorganism Reservoir: Natural environment of the pathogen Portal

More information

Received 9 August 2004/Accepted 26 October 2004

Received 9 August 2004/Accepted 26 October 2004 JOURNAL OF VIROLOGY, Mar. 2005, p. 3358 3369 Vol. 79, No. 6 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.6.3358 3369.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Protection

More information

Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission

Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission Dan H. Barouch a,b,1, Per Johan Klasse c, Jason Dufour d, Ronald S. Veazey d, and John P. Moore c,1 a Beth

More information

HIV Vaccine. Sunee Sirivichayakul, Ph.D. Faculty of Medicine Chulalongkorn University. August 22, 2014

HIV Vaccine. Sunee Sirivichayakul, Ph.D. Faculty of Medicine Chulalongkorn University. August 22, 2014 HIV Vaccine Sunee Sirivichayakul, Ph.D. Faculty of Medicine Chulalongkorn University August 22, 2014 Immunity Natural immunity Active natural immunity e.g., infection Passive natural immunity e.g., trans-placental

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006

More information

: AccuPower ZIKV(DENV, CHIKV) Multiplex Real-Time RT-PCR Kit. Copyright, Bioneer Corporation. All rights reserved.

: AccuPower ZIKV(DENV, CHIKV) Multiplex Real-Time RT-PCR Kit. Copyright, Bioneer Corporation. All rights reserved. : AccuPower ZIKV(DENV, CHIKV) Multiplex Real-Time RT-PCR Kit Copyright, Bioneer Corporation. All rights reserved. 1. Offers superior diagnostic accuracy compared to immunoassay Allows precision diagnosis,

More information

What are ADCC antibodies? Work on influenza ADCC antibodies Greenberg et al, Hashimoto et al. First describes Fluspecific

What are ADCC antibodies? Work on influenza ADCC antibodies Greenberg et al, Hashimoto et al. First describes Fluspecific 14/7/214 Acknowledgement antibodies against diverse influenza strains: Implications for universal vaccination Sinth Jegaskanda PhD Prof Stephen Kent University of Melbourne What are antibodies? Work on

More information

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic

More information

Received 16 May 2001/Accepted 30 July 2001

Received 16 May 2001/Accepted 30 July 2001 JOURNAL OF VIROLOGY, Nov. 2001, p. 10532 10536 Vol. 75, No. 21 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.21.10532 10536.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Efficient

More information

Systems Biology and Animal Models: STRIDE

Systems Biology and Animal Models: STRIDE Systems Biology and Animal Models: STRIDE Michael G Katze, Ph.D. presentation to Eighth Comparative Medicine Resource Directors Meeting May 10th, 2010 Questions What Pandemics Are We Currently Experiencing?

More information